What Siegfried Rhein does

Siegfried Rhein, S.A. de C.V. is a Mexico-based pharmaceutical company that has operated for approximately 50 years and markets more than 90 brands organized across 13 therapeutic categories, including analgesics, antiallergics, antibiotics and anti-infectives, respiratory, urology, cardio-metabolic, gastroenterology, neuroscience, dental, pediatric, rheumatology, gynecology, and dietary supplements. The company runs an in-house manufacturing plant in Mexico and maintains a COFEPRIS-aligned pharmacovigilance system, and it sustains an Integrated Management System certification (POL.003) for the eighth consecutive year, an Empresa Socialmente Responsable (ESR) distinction, and a Best Places to Work designation.

The commercial model is professional and prescription-driven. A field sales force reaches nearly 10,000 physicians daily, supplemented by medical events, continuing medical education, and congresses. To extend reach beyond the in-person sales call, the company has built a network of dedicated sub-brand digital properties (Furacin, Libertad Ilimitada, NutriBaby, Febrax, Panoto-s, Trivisol, Vive el Poder, Idrafast, Amably 24 hrs, Para los Parásitos) and a partnership with the IntraMed medical community platform, providing a direct-to-consumer and prescriber-engagement layer that complements the traditional detailing model.

As a privately held S.A. de C.V. with no public ticker, Siegfried Rhein has funded its growth primarily through debt capital from development finance and Mexican banking institutions. The company raised a $104M IFC loan in 2018, a $160M syndicated facility in 2019 led by IFC with Bancomext and Monex, and a $30M IFC follow-on in August 2022, for an aggregate of roughly $294M in debt funding across four years. Active hiring via OCC Mundial, an ongoing intern program, and continuous sub-brand and content production indicate that capital is being deployed into commercial scale-up, digital ecosystem buildout, and manufacturing capacity.

Name

Siegfried Rhein

Legal name

Siegfried Rhein, S.A. de C.V.

Website

https://siegfried.com.mx

Company type

Private

Founded year

1975

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Mexican pharmaceutical company founded ~1975 that markets 90+ brands across 13 therapeutic categories through a professional sales force reaching 10,000 physicians daily, supported by in-house manufacturing, a network of sub-brand digital properties, and approximately $294M of IFC and Mexican-bank debt funding since 2018.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmacies and Drug Retailers (45611)

SIC

Pharmaceutical Preparations (2834), Retail-Drug Stores And Proprietary Stores (5912), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)

akta.pro secondary industries

Probiotics & Digestive Health Supplements (CRADAGAF), Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC) (CRADAMAE)

Keywords

• Pharmaceutical manufacturing
• Therapeutic medications
• Prescription drugs
• Generic pharmaceuticals
• Healthcare products

Headquarters

HQ city

Mexico City

HQ country

Mexico

HQ region

Latin America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure

Revenue model

1. Pharmaceutical product sales: Primary revenue from manufacturing, commercialization, and distribution of pharmaceutical products (90+ brands) prescribed by healthcare professionals across 13 therapeutic areas. Distributed via prescription-based channels through physicians.
2. Distribution of adjacent health/consumer products: Secondary revenue stream from distribution of hygienic products, healing materials, nutritional supplements, cosmetics, and hydrating beverages for human use.

Pricing tiers

Go-to-market motion4 records

Core offering

Siegfried Rhein is a Mexican pharmaceutical company that develops, produces, and commercializes more than 90 brands of prescription and therapeutic pharmaceutical products organized across 13 therapeutic lines (analgesics, antiallergics, antibiotics/anti-infectives, respiratory, urological, cardio/metabolic, gastroenterological, neuroscience, dental, pediatric, rheumatological, gynecological, and dietary supplements). It also distributes adjacent health and consumer products (hygienic products, healing materials, nutritional products, cosmetics, and hydrating beverages) and supports 10 dedicated consumer sub-brands with their own websites.

Product overview

Siegfried Rhein is a Mexican pharmaceutical company with 50 years of experience in Mexico, offering a portfolio of more than 90 brands across 13 therapeutic lines: Analgésicos (analgesics), Antialérgicos (antiallergics), Antibióticos Antiinfecciosos (antibiotics/anti-infectives), Respiratorios (respiratory), Urológicos (urological), Cardio / Metabólicos (cardio/metabolic), Gastroenterológicos (gastroenterological), Neurociencias (neurosciences), Odontológicos (dental), Pediátricos (pediatric), Reumatológicos (rheumatological), Ginecológicos (gynecological), and Suplementos Alimenticios (food supplements). The product portfolio spans newborn to older-adult therapeutic needs and is supported by dedicated sub-brands with their own consumer websites — Furacin, Libertad Ilimitada, Panoto-s, NutriBaby, Febrax, Trivisol, Vive el Poder, Idrafast, Amably 24 hrs, and Para los Parásitos. Around the core pharmaceutical catalog, Siegfried Rhein runs supporting digital channels: IntraMed (a medical community platform), Espacio Medical (a science content portal for health professionals), Sistema Certificado (Integrated Management System governance portal), a Notas de salud / Espacio de Salud blog publishing roughly eight new health articles per month, a press zone (Zona de prensa), an events section, and a sales force that reaches nearly 10,000 physicians daily.

Differentiator

Problem solved

Functional benefit

Brands

• Furacin:
• Libertad Ilimitada
• Panoto-s
• NutriBaby
• Febrax
• Trivisol
• Vive el Poder
• Idrafast
• Amably 24 hrs
• Para los Parásitos

Products and services

• Analgésicos (Analgesics) Therapeutic line of products directed at managing pain of various types and intensities, also useful for inflammation and fever control. Targeted at prescribing physicians and patients.
• Antialérgicos (Antiallergics) Therapeutic line of antihistamines mainly directed at managing and controlling uncomfortable symptoms caused by allergies. Targeted at prescribing physicians and patients.
• Antibióticos Antiinfecciosos (Antibiotics / Anti-infectives) Therapeutic line of broad-spectrum antibiotics directed at treating infectious diseases caused by bacteria, helping to prevent future complications. Targeted at prescribing physicians and patients.
• Respiratorios (Respiratory) Therapeutic line offering a wide range of solutions aimed at improving or controlling various symptoms affecting the proper functioning of the respiratory system. Targeted at prescribing physicians and patients.
• Urológicos (Urological) Therapeutic line for urinary system use offering options to treat or alleviate various symptoms caused by infections, micturition problems secondary to prostate growth, erectile dysfunction, and other pathologies. Targeted at prescribing physicians and patients.
• Cardio / Metabólicos (Cardio/Metabolic) Therapeutic line used in managing diseases affecting the heart and circulatory system, as well as metabolic disorders related to glucose and lipid control, important for pathologies affecting the general population. Targeted at prescribing physicians and patients.
• Gastroenterológicos (Gastroenterological) Therapeutic line focused on managing pain, promoting intestinal movement, and even parasitic eradication in pathologies affecting the digestive system. Targeted at prescribing physicians and patients.
• Neurociencias (Neuroscience) Therapeutic line acting on the nervous system focused on therapies for managing depression, bipolar disorder, schizophrenia, epilepsy, and other conditions with the aim of helping patients recover their quality of life. Targeted at prescribing physicians and patients.
• Odontológicos (Dental) Therapeutic line covering dental therapeutics, including pain and inflammation control, eradication of dental infections, and combination therapies to maintain healthy teeth and gums. Targeted at prescribing dentists and patients.
• Pediátricos (Pediatric) Therapeutic line of pediatric medications formulated specifically to treat medical conditions in babies and children, taking into account their unique needs and development. Targeted at prescribing pediatricians and parents/caregivers.
• Reumatológicos (Rheumatological) Therapeutic line offering high-quality standards alternatives for rheumatological conditions focused on pain management, symptom improvement, and quality of life. Targeted at prescribing physicians and patients.
• Ginecológicos (Gynecological) Therapeutic line addressing feminine pathologies, focused on preserving women's health across all life stages including bone mass, hormones, birth control, and metabolic state. Targeted at prescribing gynecologists and patients.
• Suplementos Alimenticios (Food Supplements) Complementary nutritional alternatives developed to meet nutritional needs from the smallest children to older adults. Targeted at consumers and recommended by physicians.
• Furacin Dedicated sub-brand of Siegfried Rhein with its own consumer-facing website (furacin.com.mx). Targeted at Mexican consumers/patients.
• Libertad Ilimitada Dedicated sub-brand of Siegfried Rhein with its own consumer-facing website (libertadilimitada.mx). Targeted at Mexican consumers/patients.
• Panoto-s Dedicated sub-brand of Siegfried Rhein with its own consumer-facing website (panoto-s.com.mx). Targeted at Mexican consumers/patients.
• NutriBaby Dedicated sub-brand of Siegfried Rhein with its own consumer-facing website (nutribaby.mx) focused on infant nutrition. Targeted at parents and caregivers of infants.
• Trivisol Dedicated sub-brand of Siegfried Rhein with its own consumer-facing website (trivisol.mx). Targeted at Mexican consumers/patients.
• Vive el Poder Dedicated sub-brand of Siegfried Rhein with its own consumer-facing website (viveelpoder.com.mx). Targeted at Mexican consumers/patients.
• Idrafast Dedicated sub-brand of Siegfried Rhein with its own consumer-facing website (idrafast.com). Targeted at Mexican consumers/patients.
• Amably 24 hrs Dedicated sub-brand of Siegfried Rhein with its own consumer-facing website (amably.com.mx). Targeted at Mexican consumers/patients.

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Genomma Lab Internacional: Mexican OTC and branded-generic pharmaceutical company listed on BMV. Comparable in therapeutic breadth across analgesics, gastro, dermatology, and women's health, with similar physician/consumer hybrid GTM in Mexico.
• Asofarma: Mexican pharmaceutical company offering branded generics and specialty products across women's health, CNS, and other categories. Competes directly with Siegfried Rhein's gynecological and neuro portfolios.
• Laboratorios Liomont: Privately held Mexican pharmaceutical company with in-house manufacturing and broad therapeutic coverage (analgesics, antibiotics, cardio). Direct competitor to Siegfried Rhein in Mexican prescription pharma.
• Laboratorios Pisa: One of Mexico's largest pharmaceutical companies with manufacturing and broad generic/specialty portfolio. Competes directly across multiple of Siegfried Rhein's therapeutic lines and shares the physician-channel GTM.
• Productos Maver: Mexican pharmaceutical manufacturer focused on generics and branded generics across multiple therapeutic areas. Comparable mid-sized domestic peer with similar sales-led prescription model.
• Grupo Farmacéutico Somar: Mexican specialty pharmaceutical group with manufacturing and multiple therapeutic brands. Similar business model: branded generics, domestic manufacturing, multi-brand portfolio.

Broad incumbents

• Bayer de México: Mexican subsidiary of global pharmaceutical and consumer care giant. Competes with Siegfried Rhein in women's health, analgesics, antibiotics, and consumer health categories as a broad-spectrum incumbent.
• Sanofi Mexico: Subsidiary of global Big-Pharma Sanofi operating across prescription, vaccines, and consumer health in Mexico. Overlaps with Siegfried Rhein's cardio, neuro, and consumer health portfolios as a much larger incumbent.
• Pfizer Mexico: Mexican operations of global Big-Pharma Pfizer. Competes in antibiotics, neuro, women's health, and vaccines against Siegfried Rhein's portfolio but with significantly larger R&D resources.

Regional players

• Eurofarma México: Mexican arm of Brazilian pharmaceutical company Eurofarma. Latin American mid-tier pharma with broad portfolio across multiple therapeutic categories, comparable in scale and model to Siegfried Rhein but with regional (Brazil-rooted) ambitions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Siegfried_Rhein
• LinkedInlinkedin.com/company/siegfried-rhein

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Siegfried Rhein